Belite Bio Begins IPO Effort To Advance Eye Disease Treatments (Pending:BLTE)
Belite Bio has filed to raise an undisclosed amount in an IPO. The firm is developing treatment candidates for eye diseases. Read more about BLTE's IPO here.
Source: seekingalpha.com